Doxycycline as a potential partner of COVID-19 therapies

Coronavirus disease 2019 (COVID-19) is a major public health challenge, and the current antiviral arsenal for treatment is limited, with questionable efficacy. Major efforts are under way for discovery of new effective agents, but the validation of new potential treatments for COVID-19 may take a lo...

Descripción completa

Detalles Bibliográficos
Autores principales: Malek, Alexandre E., Granwehr, Bruno P., Kontoyiannis, Dimitrios P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7298522/
https://www.ncbi.nlm.nih.gov/pubmed/32566483
http://dx.doi.org/10.1016/j.idcr.2020.e00864

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7298522/
https://www.ncbi.nlm.nih.gov/pubmed/32566483
http://dx.doi.org/10.1016/j.idcr.2020.e00864

Ejemplares similares